Isatuximab, bortezomib, lenalidomide, and limited dexamethasone in patients with transplant-ineligible multiple myeloma (REST): a multicentre, single-arm, phase 2 trial

Isatuximab, Bortezomib, Lenalidomide, and Limited Dexamethasone in Multiple Myeloma Treatment

Overview of the Study

This study explored the safety and effectiveness of isatuximab, bortezomib, lenalidomide, and limited dexamethasone for older patients with newly diagnosed multiple myeloma who are not eligible for stem cell transplants.

Study Details

Conducted between June 2021 and January 2023, the trial involved 51 participants (53% women, median age 77). Most patients remained on treatment, with 39 completing 18 cycles.

Results

  • Complete Response: 37% of patients achieved a measurable improvement in their condition.
  • Progression Rate: 35% of participants experienced disease progression or death.
  • Adverse Events: Notable side effects included neutropenia (55%), infections (41%), and thrombocytopenia (22%).

Conclusion

The combination of these treatments was found to be both effective and safe for the target patient group. Notably, removing dexamethasone after two cycles could be beneficial moving forward.

Practical Solutions and Value

This study demonstrates that a modified treatment plan can improve outcomes for older patients with multiple myeloma. Such adaptations can enhance patient care significantly.

Clinical Trials Improve Treatment

Clinical trials play a vital role in advancing safe healthcare. Our AI-driven platform, DocSym, provides a comprehensive knowledge base that integrates clinical guidelines and research to support healthcare providers effectively.

Enhancing Patient Care

Our mobile apps streamline scheduling, treatment monitoring, and telemedicine, simplifying patient management and improving service delivery.

Learn More

Discover how AI can transform workflows and enhance patient outcomes at aidevmd.com.

AI Products for Business or Try Custom Development

AI Sales Bot

Welcome AI Sales Bot, your 24/7 teammate! Engaging customers in natural language across all channels and learning from your materials, it’s a step towards efficient, enriched customer interactions and sales

AI Document Assistant

Unlock insights and drive decisions with our AI Insights Suite. Indexing your documents and data, it provides smart, AI-driven decision support, enhancing your productivity and decision-making.

AI Customer Support

Upgrade your support with our AI Assistant, reducing response times and personalizing interactions by analyzing documents and past engagements. Boost your team and customer satisfaction

AI Scrum Bot

Enhance agile management with our AI Scrum Bot, it helps to organize retrospectives. It answers queries and boosts collaboration and efficiency in your scrum processes.